# Exploratory Study of Changes in Disease Activity and Biomarkers With ABR-215757 in Patients With Mild Active Systemic Lupus Erythematosus (SLE)

> **NCT00997100** · PHASE2 · COMPLETED · sponsor: **Active Biotech AB** · enrollment: 13 (actual)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

- **DRUG:** paquinimod (ABR-215757)

## Key facts

- **NCT ID:** NCT00997100
- **Lead sponsor:** Active Biotech AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2015-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00997100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00997100, "Exploratory Study of Changes in Disease Activity and Biomarkers With ABR-215757 in Patients With Mild Active Systemic Lupus Erythematosus (SLE)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00997100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*